Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	4558.37	-363.92	7.81
Graham Fair Price	-77.47	38571.17	171175.68
PEG	15720.64	0.64	< 0.005
Price/Book	26.31	0.40	0.32
Price/Cash Flow	1000.63	110.47	10.04
Prices/Earnings	2365.53	-67.47	2.74
Price/Sales	55.48	2.54	1.63
Price/FCF	1000.63	110.47	10.04
Naive Interpretation	member

01 - Valuation · Somewhat Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	-85.17	0.04	0.30
Operating Margin	-75.43	-0.05	0.22
ROA	-94.90	< 0.005	0.02
ROE	0.03	< 0.005	-94.88
ROIC	0.03	-0.01	-50.22
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	-0.03	-0.15	82.99
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	5.97	-1.20	-79.93
EPS QOQ	6.74	-1.05	-84.42
FCF QOQ	1.68	-0.89	-47.33
Revenue QOQ	0.25	-0.19	-24.30
Naive Interpretation	member

03 - Financial Growth · Bad

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	55.32	40.60	-26.60
Days Sales Outstanding (DSO)	74.34	99.05	33.23
Inventory Turnover	1.63	2.22	36.24
Debt/Capitalization	0.08	0.08	-2.49
Quick Ratio	2.24	2.32	3.57
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	212135.14	211192.01	-0.44
Cash	37587.77	37617.07	0.08
Capex	-218.52	-313.86	-43.63
Free Cash Flow	6694.94	764.88	-88.58
Revenue	41185.53	33308.65	-19.13
Naive Interpretation	member

05 - Per Share Metrics · Bad

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	2.99	2.99	-0.09
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	1.43	-51.17	3476.36
Naive Interpretation	Member

06 - Financial Health · Bad

Rating